N/A
N=36
The Impact of Serial Remote Ischemic Conditioning on Dynamic Cerebral Autoregulation in Healthy Adults
Remote Ischemic Conditioning
Bottom Line
View on ClinicalTrials.gov: NCT04899362 ↗Enrolled (actual)
36
Serious AEs
0.0%
Results posted
Dec 2023
Primary outcome: Primary: Dynamic Cerebral Autoregulation Parameter: Phase Difference(PD) in Degree — 45.87 degree
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- BB-RIC-D1/LAPUL Medical Devices Co, Ltd, China (Device); Intravenous blood collection (Procedure); dCA measurement (Device)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- The First Hospital of Jilin University
- Primary completion
- Jul 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Dynamic Cerebral Autoregulation Parameter: Phase Difference(PD) in Degree |
45.87 | — |
| SECONDARY Dynamic Cerebral Autoregulation Parameter: Gain in cm/s/mmHg |
0.95 | — |
Summary
The purpose of this study is to determine the impact of serial remote ischemic conditioning on dynamic cerebral autoregulation and related hematology indexes in healthy adults.
Eligibility Criteria
Inclusion Criteria
- age from 18 to 50,both genders
- willing to participate in follow-up visits
Exclusion Criteria
- current or having a history of chronic physical diseases or mental diseases
- suffering from infectious diseases in late one month
- pregnant and lactating women#
- smoking or drinking#
- inability to cooperate sufficiently to complete the dCA examination
Data sourced from ClinicalTrials.gov (NCT04899362). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.